K. Fairman

K. Fairman, Titilola M. Afolabi, 2018, Nutrition in clinical practice : official publication of the American Society for Parenteral and Enteral Nutrition.

Quality Improvement Opportunities in Prescriber Alert Programs

K. Fairman, F. Curtiss, 2010, Journal of managed care pharmacy : JMCP.

Treatment Needs and Service Utilization in Older U.S. Adults Evidencing High-Risk Substance Use

K. Fairman, Nicole K. Early, 2020, Journal of aging and health.

Does Medicalization of Life Imperil Health? Expanding Indications for Diagnosis and Treatment of Chronic “Disease”

K. Fairman, F. Curtiss, 2011, Journal of managed care pharmacy : JMCP.

Contradictory Actions on Off-Label Use of Prescription Drugs? The FDA and CMS Versus the U.S. Justice Department

K. Fairman, F. Curtiss, 2009, Journal of managed care pharmacy : JMCP.

Cardiovascular Risk Factors and Provision of Lifestyle Counseling for Diabetes or Prediabetes With Comorbid Obesity: Analysis of Office-Based Physician Visits Made by Patients 20 Years of Age or Older

K. Fairman, S. Karr, D. Sclar, 2018, Diabetes Spectrum.

Description of the Outcomes of Prior Authorization of Palivizumab for Prevention of Respiratory Syncytial Virus Infection in a Managed Care Organization Medical Utilization Associated with Palivizumab Compliance in a Commercial and Managed Medicaid Health Plan

K. Fairman, D. Stewart, P. Mahadevia, 2009 .

Real-world use of PCSK-9 inhibitors by early adopters: cardiovascular risk factors, statin co-treatment, and short-term adherence in routine clinical practice

K. Fairman, D. Sclar, L. E. Davis, 2017, Therapeutics and clinical risk management.

COVID-19 Infection Fatality Rates.

K. Fairman, 2020, Health affairs.

Changes in Cause-of-Death Attribution During the Covid-19 Pandemic: Association with Hospital Quality Metrics and Implications for Future Research

K. Fairman, K. Goodlet, J. Rucker, 2020, medRxiv.

It Depends on What Mean Means: Averaging Versus Event Patterning in Analyses of Administrative Claims Data

K. Fairman, F. Curtiss, 2010, Journal of managed care pharmacy : JMCP.

Prior authorization and clopidogrel use--the truth lies in the details.

K. Fairman, F. Curtiss, Mark Jackson, 2009, Journal of managed care pharmacy : JMCP.

Association of Antibiotic Treatment Duration With Recurrence of Uncomplicated Urinary Tract Infection in Pediatric Patients

K. Fairman, Titilola M. Afolabi, K. Goodlet, 2020, The Annals of pharmacotherapy.

It's Only a Pharmacoeconomic Model--Believe It or Not

K. Fairman, F. Curtiss, 2008, Journal of Managed Care Pharmacy : JMCP.

A “Virtual Pharmacy Shelf” to Enhance the Rigor and Efficiency of Standardized-Patient OSCEs for Over-the-Counter Medication Advice

K. Fairman, Stephanie Counts, 2022, Medical Science Educator.

Nonadherence, Clinical Inertia, or Therapeutic Inertia?

K. Fairman, F. Curtiss, J. D. Allen, 2009, Journal of managed care pharmacy : JMCP.

Do Decision-Analytic Models Identify Cost-Effective Treatments? A Retrospective Look at Helicobacter Pylori Eradication

B. Motheral, K. Fairman, 2003, Journal of managed care pharmacy : JMCP.

Switching antidepressant drug therapy helps some patients some of the time--what TORDIA, STAR*D, and observational research have taught us about treatment-resistant depression.

K. Fairman, F. Curtiss, 2008, Journal of managed care pharmacy : JMCP.

Switching Antidepressant Drug Therapy Helps Some Patients Some of the Time--What TORDIA, STAR*D, and Observational Research Have Taught Us About Treatment-Resistant Depression

K. Fairman, F. Curtiss, 2008, Journal of managed care pharmacy : JMCP.

Use of Learning Management System Data to Predict Student Success in a Pharmacy Capstone Course

Erin C. Raney, K. Fairman, Kelsey Buckley, 2021, American Journal of Pharmaceutical Education.

Joint effects of advancing age and number of potentially inappropriate medication classes on risk of falls in Medicare enrollees

K. Fairman, D. Sclar, Nicole K. Early, 2019, BMC Geriatrics.

Retrospective, long-term follow-up study of the effect of a three-tier prescription drug copayment system on pharmaceutical and other medical utilization and costs.

B. Motheral, K. Fairman, R. Henderson, 2003, Clinical therapeutics.

Outcomes of medicaid beneficiaries with schizophrenia receiving clozapine only or antipsychotic combinations.

D. Velligan, M. Lage, K. Fairman, 2015, Psychiatric services.

Prevalence of depression and receipt of antidepressant pharmacotherapy among patients with Parkinson’s disease: a national assessment of US office-based physician visits

K. Fairman, D. Sclar, Alyssa M. Peckham, 2017 .

Diagnosis and Treatment of ADHD in the United States: Update by Gender and Race

K. Fairman, D. Sclar, Alyssa M. Peckham, 2020, Journal of attention disorders.

Principles in the Evaluation of Systematic Reviews

Stacy L. Haber, K. Fairman, D. Sclar, 2015, Pharmacotherapy.

Estimated Cardiovascular Risk and Guideline-Concordant Primary Prevention With Statins: Retrospective Cross-Sectional Analyses of US Ambulatory Visits Using Competing Algorithms

K. Fairman, K. Goodlet, Nicole K. Early, 2020, Journal of cardiovascular pharmacology and therapeutics.

Helicobacter Pylori Eradication in Clinical Practice: Retreatment Rates and Costs of Competing Regimens

B. Motheral, K. Fairman, 2000, The Annals of pharmacotherapy.

VBID, the PPACA, and FREEE medications: Did politics trump the evidence about cost sharing?

K. Fairman, F. Curtiss, 2012, Journal of managed care pharmacy : JMCP.

Changes in PBM Business Practices in 2019: True Innovation or More of the Same?

B. Motheral, K. Fairman, 2020, Journal of managed care & specialty pharmacy.

Utilization Management Opportunities for Palivizumab for Prophylaxis of Respiratory Syncytial Virus Complications in Infants

K. Fairman, F. Curtiss, 2010, Journal of managed care pharmacy : JMCP.

Regulatory Actions on the Off-Label Use of Prescription Drugs: Ongoing Controversy and Contradiction in 2009 and 2010

K. Fairman, F. Curtiss, 2010, Journal of managed care pharmacy : JMCP.

Clinical Quality Indicators and Provider Financial Incentives: Does Money Matter?

K. Fairman, F. Curtiss, 2010, Journal of managed care pharmacy : JMCP.

Interpreting Hazards: The Increasing Importance of Antidote to Anecdote in Managed Care

K. Fairman, 2010, Journal of managed care pharmacy : JMCP.

Fractal Mathematics in Managed Care? How a Simple and Revealing Analysis Could Improve the Forecasting and Management of Medical Costs and Events

M. Rucker, K. Fairman, 2009, Journal of managed care pharmacy : JMCP.

Selling Real-World Health Care Research to Reluctant Buyers-Evidence-Based Education or Marketing a Defective Product?

K. Fairman, F. Curtiss, 2009, Journal of managed care pharmacy : JMCP.

Call for Letters Regarding Disclosure of Potential Conflicts of Interest in the Managed Care Literature -- Too Much, Too Little, or Just About Right?

K. Fairman, F. Curtiss, 2009, Journal of managed care pharmacy : JMCP.

Differentiating Effective Data Mining From Fishing, Trapping, and Cruelty to Numbers

K. Fairman, 2007, Journal of managed care pharmacy : JMCP.

Peeking Inside the Statistical Black Box: How to Analyze Quantitative Information and Get It Right the First Time

K. Fairman, 2007, Journal of managed care pharmacy : JMCP.

Item analysis of emotional exhaustion in pharmacy practice faculty.

K. Fairman, S. El-Ibiary, Kelly C. Lee, 2020, Currents in pharmacy teaching & learning.

Unexplained mortality during the US COVID-19 pandemic: retrospective analysis of death certificate data and critical assessment of excess death calculations

K. Fairman, K. Goodlet, R. Zawadzki, 2021, BMJ Open.

Association of Medication Persistency with Route of Administration and Patient Cost-Sharing: Analysis of Commonly Used Biologics.

K. Fairman, A. Shim, H. Pham, 2015, Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research.

The Editors Respond Regarding the Shortcomings in Reported Research on Value-Based Insurance Design

K. Fairman, F. Curtiss, 2008, Journal of Managed Care Pharmacy : JMCP.

Provision of Lifestyle Counseling and the Prescribing of Pharmacotherapy for Hyperlipidemia Among US Ambulatory Patients: A National Assessment of Office-Based Physician Visits

K. Fairman, D. Sclar, Nicole K. Early, 2018, American Journal of Cardiovascular Drugs.

Real-world use of PCsK-9 inhibitors by early adopters: cardiovascular risk factors, statin co-treatment, and short-term adherence in routine clinical practice

K. Fairman, D. Sclar, Lindsay E Davis, 2017 .

10 Tips for a Great Health Care Research Article

K. Fairman, 2012, Journal of managed care pharmacy : JMCP.

Finding our Voice: Evaluation of Goal Setting Using the Habits of Preceptors Rubric in Terms of Focus, "SMARTness," and Impact.

K. Fairman, Tara Storjohann, Suzanne Larson, 2023, The Journal of continuing education in the health professions.

Authors’ Reply to: Tomoyuki Kawada’s Comment on: “All-Cause and Drug-Related Medical Events Associated with Overuse of Gabapentin and/or Opioid Medications: A Retrospective Cohort Analysis of a Commercially Insured US Population’’

K. Fairman, D. Sclar, Alyssa M. Peckham, 2018, Drug Safety.